Literature DB >> 18783514

Epidemiology of Helicobacter pylori infection.

Michael G Bruce1, Heidi Ingrid Maaroos.   

Abstract

This review summarizes studies on the epidemiology of Helicobacter pylori published in peer-reviewed journals between April 2007 and March 2008. Infection with H. pylori often occurs in childhood, and once established, can persist lifelong if untreated. Prevalence of H. pylori infection is higher in developing countries when compared to developed countries, and can vary by ethnicity, place of birth, and socioeconomic factors even among persons living in the same country. Prevalence of infection is decreasing in many countries due to improvements in sanitation and living standards and the relatively recent movement of populations from rural to urban settings; however, post-treatment recurrence rates of H. pylori infection remain high in developing countries, and in given populations within developed countries. In addition, a number of recent studies have begun to explore the possible link between childhood infection with H. pylori and protection against asthma and allergy.

Entities:  

Mesh:

Year:  2008        PMID: 18783514     DOI: 10.1111/j.1523-5378.2008.00631.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  44 in total

1.  Unraveling the Helicobacter pylori UreG zinc binding site using X-ray absorption spectroscopy (XAS) and structural modeling.

Authors:  Vlad Martin-Diaconescu; Matteo Bellucci; Francesco Musiani; Stefano Ciurli; Michael J Maroney
Journal:  J Biol Inorg Chem       Date:  2011-11-09       Impact factor: 3.358

2.  Membrane-associated activation of cholesterol α-glucosyltransferase, an enzyme responsible for biosynthesis of cholesteryl-α-D-glucopyranoside in Helicobacter pylori critical for its survival.

Authors:  Hitomi Hoshino; Akiko Tsuchida; Kiyokazu Kametani; Masako Mori; Tomoko Nishizawa; Takefumi Suzuki; Hitomi Nakamura; Heeseob Lee; Yuki Ito; Motohiro Kobayashi; Junya Masumoto; Masaya Fujita; Minoru Fukuda; Jun Nakayama
Journal:  J Histochem Cytochem       Date:  2011-01       Impact factor: 2.479

3.  Alaska sentinel surveillance study of Helicobacter pylori isolates from Alaska Native persons from 2000 to 2008.

Authors:  Adrienne H Tveit; Michael G Bruce; Dana L Bruden; Julie Morris; Alisa Reasonover; Debby A Hurlburt; Thomas W Hennessy; Brian McMahon
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

4.  Oral nitrate reductase activity and erosive gastro-esophageal reflux disease: a nitrate hypothesis for GERD pathogenesis.

Authors:  Siavosh Nasseri-Moghaddam; Habibeh Nokhbeh-Zaeem; Parastoo Saniee; Shahrzad Pedramnia; Masoud Sotoudeh; Reza Malekzadeh
Journal:  Dig Dis Sci       Date:  2011-09-01       Impact factor: 3.199

5.  Helicobacter pylori: is it a complete villain?

Authors:  Walter J Coyle
Journal:  Curr Gastroenterol Rep       Date:  2011-08

Review 6.  Novel insights on the role of CD8+ T cells and cytotoxic responses during Helicobacter pylori infection.

Authors:  Barbara Kronsteiner; Josep Bassaganya-Riera; Noah Philipson; Raquel Hontecillas
Journal:  Gut Microbes       Date:  2014-04-22

7.  Helicobacter pylori eradication by sitafloxacin-lansoprazole combination and sitafloxacin pharmacokinetics in Mongolian gerbils and its in vitro activity and resistance development.

Authors:  Tatsuo Yamamoto; Tomomi Takano; Wataru Higuchi; Akihito Nishiyama; Ikue Taneike; Kumi Yoshida; Hiroko Kanda; Yuichiro Imamura
Journal:  Antimicrob Agents Chemother       Date:  2011-07-05       Impact factor: 5.191

8.  ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

Authors:  William D Chey; Grigorios I Leontiadis; Colin W Howden; Steven F Moss
Journal:  Am J Gastroenterol       Date:  2017-01-10       Impact factor: 10.864

9.  Correlates shift work with increased risk of gastrointestinal complaints or frequency of gastritis or peptic ulcer in H. pylori-infected shift workers?

Authors:  Anke van Mark; Michael Spallek; David A Groneberg; Richard Kessel; Stephan W Weiler
Journal:  Int Arch Occup Environ Health       Date:  2009-12-11       Impact factor: 3.015

Review 10.  Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line.

Authors:  Simona Di Caro; Lucia Fini; Yayha Daoud; Fabio Grizzi; Antonio Gasbarrini; Antonino De Lorenzo; Laura Di Renzo; Sara McCartney; Stuart Bloom
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.